Integra Lifesciences Holdings (IART) Current Assets (2009 - 2026)

Integra Lifesciences Holdings' Current Assets history runs 18 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Current Assets rose 5.85% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 5.85% YoY), while the FY2025 annual figure was $1.2 billion, up 7.2% from the prior year.
• Current Assets came in at $1.2 billion for Q1 2026 at Integra Lifesciences Holdings, up from $1.2 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.4 billion in Q1 2024 to a low of $1.0 billion in Q3 2023.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 37.51% in 2024 and declined 21.79% in 2025, its largest moves.
• Integra Lifesciences Holdings' Current Assets stood at $1.2 billion in 2022, then decreased by 8.91% to $1.1 billion in 2023, then advanced by 2.23% to $1.1 billion in 2024, then rose by 7.2% to $1.2 billion in 2025, then grew by 1.08% to $1.2 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $1.2 billion, $1.2 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison